[Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives]

Onkologie. 2001 Feb;24(1):81-6. doi: 10.1159/000050288.
[Article in German]
No abstract available

MeSH terms

  • Amifostine / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Cell Survival / drug effects
  • Clinical Trials as Topic
  • Cytoprotection* / drug effects
  • Cytoprotection* / radiation effects
  • Humans
  • Mesna / administration & dosage
  • Neoplasms / drug therapy*
  • Palliative Care / methods*
  • Practice Guidelines as Topic
  • Radiation-Protective Agents / administration & dosage

Substances

  • Antineoplastic Agents
  • Radiation-Protective Agents
  • Amifostine
  • Mesna